MATTES GLENN R. (President and CEO) sold 91.6% of their position (108.83K shares) of TFF PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $1.63M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/13/2020ACC: 0001213900-20-037057
DirectorOfficer· President and CEO
Since Oct 2019
-108.83K
Net shares
Net seller
$1.63M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
108.83K acquired · 217.66K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+108.83K
Price / share
$2.50
Trade value
$272.07K
% of position
1088.3%
11/10/2020
10K→118.83K
Common Stock
Direct
Shares
−108.83K
Price / share
$14.99
Trade value
$1.63M
% of position
91.6%
11/10/2020
118.83K→10K
Total
Net shares
+0.00
Net value
-$1.36M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/10/2020 | M · Option Exercise | +108.83K | $2.50 | $272.07K | 1088.3% | 10K | 118.83K |
| Common Stock Direct | 11/10/2020 | S · Sale | −108.83K | $14.99 | $1.63M | 91.6% | 118.83K | 10K |
| Total | +0.00 | -$1.36M | ||||||
Derivative Transactions1
Stock Options (Right to Buy)
Direct
Converts to
Common Stock
108.83K shares
Shares
−108.83K
Strike price
2.50
Held after
1.10M
Exercisable
—
11/10/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) Direct | Common Stock108.83K shares | 11/10/2020 | M · Option Exercise | −108.83K | 2.50 | — | 1.10M |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned10K
Total
10K indirect10K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 10K | Indirect |
| Total | 10K | 10K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported